Top Industry Leaders in the Benzathine Penicillin G Market
Latest Benzathine Penicillin G Companies Updates:
Teva Pharmaceuticals (Israel) Launched their MORPHIZE™ Extended Release (XR) Injectable in the US, offering a long-acting BPG injection with potentially reduced dosing frequency.
Grünenthal GmbH (Germany) Introduced their MORPIRIN® oral morphine tablets with enhanced tamper-resistant features to address opioid diversion concerns.
World Health Organization (WHO) Continued advocating for improved access to BPG through their "Left Behind in Pain" campaign and collaborations with governments and healthcare organizations.
Pfizer (US) The sole supplier of BPG in many countries, including the US, announced a shortage in July 2023 due to increased demand for syphilis treatment. They currently estimate recovery by April 2024.
WHO and other organizations Raised concerns about the shortage's impact on access to essential syphilis treatment, particularly in low- and middle-income countries. They are advocating for alternative treatment options and long-term solutions to ensure consistent BPG availability.
List of Benzathine Penicillin G Key companies in the market
- Pfizer Inc
- Alembic IT Department
- ECPlaza Network Inc
- Abcam plc
- Sandoz International GmbH
- Merck KGaA
- Triveni Interchem Private Limited
- CSC Pharmaceuticals